News

MINSA approved the Technical Document: Management of people affected by COVID-19 in hospitalization services

El Ministerio de Salud a través de la Resolución Ministerial Nº 839-2020/MINSA, publicada el 13 de octubre del 2020 en el Diario Oficial “El Peruano”, aprobó el “Documento Técnico: Manejo de personas afectadas por COVID-19 en los servicios de hospitalización” que como Anexo forma parte integrante de la mencionada Resolución Ministerial, así también deja sin efecto el numeral 7.9 del “Documento Técnico: Prevención, Diagnóstico y Tratamiento de personas afectadas por COVID-19 en el Perú”, referido a los tratamientos farmacológicos específicos para COVID-19, en el que se incluían a medicamentos como el Fosfato de Cloroquina, la Hidroxicloroquina y la combinación de la Hidroxicloroquina con la Azitromicina.

Documento completo: Click aqui

Fuente de referencia: Click aqui

Source: Official Gazette "El Peruano"

Recent posts

Modificaciones de Seguridad de la DIGEMID: Para las Especialidades Farmacéuticas que contienen “FLUOROURACILO”

El MINSA aprobó el “Documento Técnico: Manual de Buenas Prácticas de Farmacovigilancia”

MINSA approved the Technical Health Standard that regulates Good Laboratory Practices for Preclinical Studies (GLP-PC) in the Research and Development of Pharmaceutical Products

Extension of the declaration of Sanitary Emergency

The MINSA included in the PNUME for the Health Sector, the product Medicinal Oxygen 93% gas for inhalation

MINSA ordered the publication of the Regulation Project that establishes specific provisions for conducting Clinical Trials with Medical Devices

The MINSA approved the Sanitary Directive for the use of Oxygen in Institutions Providers of Health Services and home use

MINSA approved the Technical Document: National Vaccination Plan against COVID-19

The MINSA orders the publication of the Technical Document project: Manual of Citizen Participation in the elaboration of the PNUME

MINSA approved the Technical Document: Management of people affected by COVID-19 in hospitalization services

MINSA approved the technical document: Guidelines for the exceptional health authorization of medical devices in the research stage

Urgent decree that dictates extraordinary measures to facilitate and guarantee the acquisition, conservation and distribution of vaccines against COVID-19

The MINSA plans to publish a draft ministerial resolution that resolves to include in the PNUME for the health sector, the medicinal oxygen product 93% gas

DIGEMID safety modifications: For pharmaceutical specialties containing "MELOXICAM"

The MINSA approves the update of the scale for infractions and sanctions to pharmaceutical and non-pharmaceutical establishments of the regulation of pharmaceutical establishments

DIGEMID safety modifications: For pharmaceutical products containing "Bacillus Clausii"

DIGEMID safety modifications: For pharmaceutical specialties containing "MONTELUKAST"

DIGEMID safety modifications: For pharmaceutical specialties containing "LORCASERIN"

DIGEMID safety modifications: For pharmaceutical specialties that contain "FENOTEROL"

The MINSA modified the Regulation of Narcotic Drugs, Psychotropic Drugs and Other Substances subject to Sanitary Inspection